Open AccessThe effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA
Author(s) -
Waleed Al Taweel,
Khalil Mohammed Alzyoud
Publication year - 2015
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/0974-7796.152013
Subject(s) - medicine , spinal cord injury , urinary incontinence , visual analogue scale , urinary system , detrusor muscle , urology , urodynamic testing , urinalysis , refractory (planetary science) , quality of life (healthcare) , urinary bladder , anesthesia , spinal cord , physics , nursing , psychiatry , astrobiology
The aim was to report the effectiveness and safety OnabotulinumtoxinA (Botox, Allergan, Inc., Irvine, CA, USA) intradetrusor injections in spinal cord-injured (SCI) patients with refractory neurogenic detrusor overactivity. And to assess the result based on SCI level.